|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 USD | +4.44% |
|
-4.31% | -28.83% |
| Mar. 06 | Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
| Mar. 06 | Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M | MT |
InspireMD, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 6.21 million compared to USD 5.17 million a year ago. Net loss was USD 19.92 million compared to USD 18.49 million a year ago.
Basic loss per share from continuing operations was USD 0.82 compared to USD 2.35 a year ago. Diluted loss per share from continuing operations was USD 0.82 compared to USD 2.35 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.83% | 46.85M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
INSPIREMD, INC. 
